Firstly, we ensured the expression of FTX and the percentage of M1 and M2 KCs in diseased liver tissues from NAFLD and NAFLD-HCC patients and adjacent normal tissues from NAFLD-HCC patients. Here, FTX is linked to metabolic dysfunction-associated steatotic liver disease.